MIR4679-2

Across TCGA pan-cancer cohorts, MIR4679-2 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR4679-2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4679-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4679-2 expression acts as an unfavorable survival marker.

KIRC, LUSC, and BLCA are the cancer types where MIR4679-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.197	0.568	<.001	66	view →
LUSC	OS	Tertile	II,III,IV	0.217	0.638	<.001	36	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	27	view →
BRCA	OS	Tertile	III,IV	0.152	0.556	.001	24	view →
THCA	DFS	Tertile	III,IV	0.421	0.701	.030	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR4679-2–KIRC (OS)

Open the KIRC breakdown →